Baker Brothers Advisors - FORMA THERAPEUTICS HLDGS INC ownership

FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 107 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q2 2022. The put-call ratio across all filers is 6.48 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of FORMA THERAPEUTICS HLDGS INC
ValueSharesWeighting
Q3 2022$37,641,000
+169.8%
1,886,760
-6.8%
0.25%
+212.7%
Q2 2022$13,951,000
-25.9%
2,024,8760.0%0.08%
-26.9%
Q1 2022$18,831,000
-34.6%
2,024,8760.0%0.11%
-22.9%
Q4 2021$28,794,000
-38.7%
2,024,8760.0%0.14%
-32.0%
Q3 2021$46,957,000
-6.8%
2,024,8760.0%0.21%
-6.8%
Q2 2021$50,399,000
-11.2%
2,024,8760.0%0.22%
-10.2%
Q1 2021$56,737,000
-19.7%
2,024,8760.0%0.25%
-7.5%
Q4 2020$70,668,000
-20.0%
2,024,876
+14.3%
0.27%
-24.6%
Q3 2020$88,292,000
-5.0%
1,771,509
-11.4%
0.35%
-13.9%
Q2 2020$92,980,0002,000,0000.41%
Other shareholders
FORMA THERAPEUTICS HLDGS INC shareholders Q2 2022
NameSharesValueWeighting ↓
EDBI Pte Ltd 1,268,805$18,042,0009.80%
Samsara BioCapital, LLC 1,565,526$22,262,0004.32%
Cormorant Asset Management, LP 4,639,995$65,981,0003.92%
Logos Global Management LP 1,600,000$22,752,0002.35%
RA Capital Management 9,011,651$128,146,0002.26%
HighVista Strategies LLC 40,612$578,0000.46%
ARMISTICE CAPITAL, LLC 1,856,000$26,392,0000.43%
Artal Group S.A. 1,000,000$14,220,0000.39%
Parkman Healthcare Partners LLC 100,000$1,422,0000.31%
Integral Health Asset Management, LLC 75,000$1,067,0000.30%
View complete list of FORMA THERAPEUTICS HLDGS INC shareholders